Desk›Chemicals› Link Pharma Chem Ltd
Link Pharma Chem Ltd
BSE 524748 · NSE LINKPH · ISIN INE302F01011 · Group X · Active
Commodities › Chemicals › Chemicals & Petrochemicals › Commodity Chemicals
₹28.00
+0.00%
BSE close, 28 August 2026
₹12.43 cr
0.4 cr shares · Micro cap
₹6.03 cr
as published
-1,400.0× · 0.91×
EPS ₹-0.02 · BV ₹30.77
27.43 / 0.08
₹ cr, as filed
14
4 selected · 29%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -33.2% |
|---|---|
| Against 52-week low | +33.3% |
| Day change | +0.00% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.02 |
|---|---|
| Price / earnings | -1,400.00× |
| Price / book | 0.91× |
| Book value — derived, price ÷ P/B | ₹30.77 |
| Return on equity | -0.05% |
| Operating margin | 9.18% |
| Net margin | 3.63% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -0.07%
- ROE as published
- -0.05%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 8.77 | 0.32 | 0.72 | 9.18% | 3.63% |
| Mar-26 · Q | 6.59 | -0.41 | -0.92 | -1.40% | -6.21% |
| FY25-26 | 27.43 | 0.08 | 0.17 | 6.00% | 0.28% |
Quarter on quarter
- Revenue, quarter on quarter
- +33.1%
- Net profit, quarter on quarter
- +178.0%
- Operating margin, quarter on quarter
- +1,058 bps
Disclosure profile 14 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 2 |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 4 |
| Procedural | |
| AGM / EGM | 4 |
| Newspaper Publication | 2 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Book Closure | 1 |
| General | 1 |
| Procedural sub-total | 10 |
| Total | 14 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
14 filings · 4 selected · busiest 2026-08-20
Filing rhythm · the twelve most recent
2026-07-272026-08-20
SelectedProcedural
Filings
14 in the window · 2 earlier on record
-
20 August 2026 ·
Change in Management
Re-appointment of Mr. Satish G. Thakur as Whole Time Director for 3 years.
Company Update / Change in Management View filing →
-
20 August 2026 ·
Change in Management
Re-appointment of Mr. Rishikesh Thakur as Managing Director of the Company for 3 years.
Company Update / Change in Management View filing →
-
20 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results pursuant to clause 44(3) of SEBI LODR Regulation,2015 and Scrutinizer's report for 41st Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
20 August 2026 ·
Voting Results Pursuant To Clause 44 (3) Of SEBI LODR Regulations 2015 And Report Of Scrutinizer
Voting Results pursuant to clause 44(3) of SEBI LODR Regulations, 2015, and Scrutinizer's report for 41st Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
20 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary proceeding of 41st Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
6 August 2026 ·
Newspaper Publication
Newspaper publication of Unaudited Financial results of the Company for the Quarter ended June 30, 2026 published on 06th August, 2026 in Business Standard (English edition) and Loksatta ....
Company Update / Newspaper Publication View filing →
-
5 August 2026 ·
Unaudited Financial Results Of The Company For Quarter Ended June 30, 2026.
Unaudited Financial results of the Company for quarter ended June 30, 2026.
Result / Financial Results View filing →
-
5 August 2026 ·
Board Meeting Outcome for Board Meeting Held On 05Th August, 2026.
Outcome of Board Meeting held on 05th August, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
28 July 2026 ·
Intimation Regarding Dispatch Of Letter Containing Web Link Of Annual Report 2025-2026 Pursuant To Regulation 36(1) (B) Of SEBI ( LODR) Regulations, 2015.
Intimation regarding dispatch of letter containing web link of Annual Report 2025-2026 pursuant to Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015.
Company Update / General View filing →
-
28 July 2026 ·
Newspaper Publication
Newspaper advertisement of Notice of 41st Annual General Meeting.
Company Update / Newspaper Publication View filing →
-
28 July 2026 ·
Board Meeting Intimation for Inter -Alia, To Consider And Approve Unaudited Financial Results Of The Company For The Quarter Ended On June 30, 2026.
Link Pharma Chem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Unaudited Financial results ....
Board Meeting / Board Meeting View filing →
-
27 July 2026 ·
Intimation Of Book Closure For The Purpose Of 41St Annual General Meeting.
Intimation of Book closure pursuant to section 91 of Companies Act, 2013 and Regulation 42 of SEBI (LODR) Regulations, 2015 for the purpose of 41st Annual General meeting.
Corp. Action / Book Closure View filing →
-
27 July 2026 ·
Reg. 34 (1) Annual Report.
Submission of Annual Report for the financial year 2025-2026 and Notice convening the 41st Annual General Meeting of the Company under Regulation 34 of the SEBI (Listing Obligations and ....
Others / Reg. 34 (1) Annual Report View filing →
-
27 July 2026 ·
Notice Of 41St Annual General Meeting Of The Company.
Notice of 41st Annual general Meeting of the Company Scheduled To be held on Thursday, 20th August, 2026 At 11:30 A.M.(IST).
AGM/EGM / AGM View filing →
RSS feed for Link Pharma Chem Ltd · the 50 most recent filings